Deploy your own COVID-19 assessment and test in one day
A site with your brand, a quiz based on the CDC's testing criteria, a zero contact COVID-19 at home test under FDA Emergency Use Authorization
How It Works:
Take the Assessment
Complete a questionnaire to assess your risk of infection. Based on conditions set by the CDC, our system may qualify you for at-home testing.
Collect Your Sample
Carefully follow the onscreen instruction at 1health.io/register and proceed to collect your saliva in the provided tube. Then return it via USPS in the complimentary priority shipping return mailer.
Await Your Results
Results will be made available within 72 hours of the lab receiving your sample. Please view your results immediately and follow the recommendations given.
The First FDA Emergency Use Authorized
At-Home Saliva COVID-19 Test
Our self-collected testing kit for COVID-19 uses a hassle-free saliva sample to determine if you are infected with the SARS-CoV-2 virus. We’ve partnered with RUCDR Infinite Biologics lab operating under the Emergency Use Authorization guidelines issued by the FDA. Our testing kits ship with priority postage for the fast delivery to your home and back to the lab. Within 72 hours of the lab receiving your sample, you will receive secure digital results.
Saliva Collection Tube
Digital Results Available Within:
72 hours of the lab receiving the sample
Before purchasing this test, you must complete an eligibility questionnaire developed in accordance with the Centers for Disease Control and Prevention (CDC) recommendations.
This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
For Constituents, Customers, and Employees:
- Quickly assess large populations for COVID-19 risk
- Engage quarantined individuals with our Stay Healthy Dashboard
- Test individuals at high risk for COVID-19 at home
- Keep people without severe symptoms away from crowded hospitals
- Contact tracing to notify those who were exposed to someone who tested positive for COVID-19